Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsReiterationPrice Target
Truist Securities analyst David Macdonald reiterates Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $290 to $305.
Truist Securities analyst David Macdonald reiterates Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $290 to $305.